Physician profile
Frank Hsu
NPI 1104454362
$1,277.60
in general payments reported to CMS, 2019-2025
8 companies · $474 in 2025
The $474 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $191 · 2023: $442 · 2024: $171 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679 · Education: $408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.09 |
| Education | $407.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $412.30 | 2023-2024 | Corevalve Evolut R, Endurant Iis |
| Abbott Laboratories | $278.90 | 2025 | Ensite, Mitraclip |
| Novo Nordisk INC | $190.66 | 2022 | |
| Penumbra, INC. | $131.18 | 2025 | Indigo System |
| Cardiva Medical, INC. | $97.12 | 2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Edwards Lifesciences Corporation | $82.63 | 2024-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $43.82 | 2023-2025 | Latitude Communicator Power Supply, Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $40.99 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.